Viome Life Sciences Raises $67M in Funding

viome

Viome Existence Sciences, a Bellevue, WA-based virtual well being corporate, raised $67M in investment.

The spherical was once led via Daring Capital Team, with participation from current buyers Khosla Ventures, West River Team, Glico, Ocgrow Ventures, and Doctor Companions.

The corporate intends to make use of the finances to strengthen the continual building of its product pipeline, together with the Oral Well being Intelligence Check, early detection diagnostic exams for continual sicknesses, and cancers.

Led via Founder & CEO Naveen Jain, Viome Existence Sciences is a biotechnology corporate introduced in 2016 to handle the epidemic of continual sicknesses, most cancers, and growing older. The corporate evolved a set of cutting edge diagnostic gear to empower over part one million customers to check, no longer bet, and to obtain actionable insights to empower every folks to are living an extended and more fit lifestyles. Viome’s proprietary means combines novel mRNA analysis and FDA-backed generation to investigate epigenetic biomarkers to ship complete, AI-driven well being insights to form a wholesome lifespan.

The newest spherical follows the release of Viome’s first CancerDetect™ take a look at for oral & throat cancers. This at-home early diagnostic software can stumble on early biomarkers related to oral and throat most cancers with top charges of specificity and sensitivity. CancerDetect™ is powered via Viome’s proprietary mRNA sequencing generation and AI-powered platform, which the FDA awarded Step forward Tool Designation standing in Might of 2021.

Within the coming months, Viome will leverage this investment to debut a set of latest wellness and diagnostic exams in particular concentrated on the oral microbiome. Construction upon the luck of CancerDetect™ for oral and throat most cancers, the corporate may be using this identical generation to energy early detection for extra hard-to-detect cancers and GI issues reminiscent of IBD.

FinSMEs

19/10/2022

Leave a Comment